3 May 2013 - Deborah Wilkes
This NEWS EXTRA publication from OTCToolbox is designed to update you on GlaxoSmithKline's strategy for its worldwide Consumer Healthcare division.
GlaxoSmithKline's recent decision to divest its Lucozade and Ribena nutritional drinks is another step in the company’s strategy of transforming its worldwide Consumer Healthcare division into the world’s “first and best fast-moving consumer healthcare” operation.
Just over 2,000 words long, this 10-page NEWS EXTRA looks at GlaxoSmithKline Consumer Healthcare's new strategy of focusing on priority brands and emerging markets. It covers the approach to the Indian market, developments in China, product innovations and financial performance, as well as recent acquisitions and divestments.
RAPID INSIGHTS MADE EASY
AVAILABLE TO DOWNLOAD IMMEDIATELY AS A PDF
See Payment Options box on this page
This NEWS EXTRA is also available as part of an Annual Subscription to the OTCToolbox website (click here to find out more).
For alternative payment options and delivery methods, or other questions, please send an email to email@example.com.